Your session is about to expire
← Back to Search
Medication Monitoring for Adolescent Asthma
N/A
Waitlist Available
Led By Heather EH De Keyser, MD MS
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of asthma
On an inhaled controller and rescue medication for which a propeller health device is available
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will study how well teens with asthma follow their medication regimen using an electronic device.
Who is the study for?
This trial is for adolescents with asthma who are using both a controller and rescue inhaler compatible with an electronic monitor. They must have been diagnosed with asthma and be able to communicate in English, Spanish, Catalan, Dutch, French, German or Italian. Those with tracheostomy, interstitial lung disease, significant developmental delays or other serious chronic lung conditions like cystic fibrosis aren't eligible.Check my eligibility
What is being tested?
The study aims to understand how well adolescents follow their prescribed asthma treatment by using an electronic device that monitors medication usage.See study design
What are the potential side effects?
Since the trial involves monitoring medication use rather than testing new drugs, there are no direct side effects from the intervention being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with asthma.
Select...
I use an inhaler that can be monitored with a Propeller device.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Treatment Phenotypes
Secondary outcome measures
Qualitative information regarding barriers for medication use
Qualitative information regarding facilitators for medication use
Trial Design
1Treatment groups
Experimental Treatment
Group I: CohortExperimental Treatment1 Intervention
Participants will be enrolled in medication use monitoring. Their medication use patterns will be available to themselves and their guardians via a smartphone application, and to their asthma care providers via a portal. There will be no interventions to change medication use patterns. A portion of them will be asked to participate in a semistructured interview during which they will be asked questions about their perception of their asthma, health beliefs regarding medication use, and what they feel would be the most helpful to get them to take their asthma medicines.
Additionally a small group of healthcare providers will be asked to participate in a focus group to collect qualitative data on medication use barriers and facilitators
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,734 Previous Clinical Trials
2,148,763 Total Patients Enrolled
Heather EH De Keyser, MD MSPrincipal InvestigatorUniversity of Colorado, Denver
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have interstitial lung disease.I have long-term breathing problems.You have a major delay in your development.I have a long-term lung condition.My primary language is not English, Spanish, Catalan, Dutch, French, German, or Italian.I have cystic fibrosis.I have a tracheostomy.I have been diagnosed with asthma.I use an inhaler that can be monitored with a Propeller device.I am taking more than 3 medications for my asthma.
Research Study Groups:
This trial has the following groups:- Group 1: Cohort
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people are participating in this clinical research?
"Indeed, the information available on clinicaltrials.gov validates that this medical study is still engaged in patient recruitment. It was initially put up to public notice as of November 16th 2020 and its most recent modifications were made on December 28th 2021. Nearly 120 patients must be gathered from a single research site for successful completion of the trial."
Answered by AI
Does this investigation accept participants who are 18 years or older?
"Applicants that meet the age requirement of between 12 and 90 years old are eligible for participation in this trial."
Answered by AI
Do I meet the requirements to join this experiment?
"A recruitment of 120 individuals, aged between 12 and 90, is underway for this trial. To qualify for participation, patients must have a diagnosis of asthma and be consistently taking both controller medication as well as rescue medicine with an accompanying propeller health device."
Answered by AI
Are there any unfilled vacancies for participants in this research?
"Affirmative. According to clinicaltrials.gov, this active study has been advertised since November 16th 2020 and was last updated on December 28th 2021, indicating that it is actively seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger